GE GEHC GE HealthCare Technologies Inc. Common Stock Loading... : Bullish and Bearish Analyst Opinions

Long medtech and digital health names as rising semiconductor content in medical devices drives growth in imaging, monitoring, robotics, and wearables.

Long medical imaging hardware suppliers as improving MRI component demand signals a recovery in production activity.

Bearish view on GEHC on the view that semiconductor memory cost inflation will hit margins, as the CFO's estimates appear too low given supply chain pressures.

The tweet suggests portfolio managers have built careers betting against Jay Saccaro's leadership at GE HealthCare and Baxter, implying a bearish outlook on both stocks.

GE HealthCare trades at 16x earnings, while its medtech peers trade at 29-37x. The company has a $21.8B order backlog and is pivoting to higher-margin AI diagnostics and recurring software revenue. The market misclassifies GEHC as a cyclical equipment maker, failing to recognize its transformation into a higher-growth, higher-margin medtech company. This misperception creates a significant valuation gap. The stock offers a compelling opportunity for multiple expansion as the market recognizes its successful pivot to AI and software, supported by a strong backlog and clear growth path. The pivot to AI and software may be slower or less profitable than anticipated; competition in the medtech space could intensify; hospital capital expenditure could slow down.